Vanrafia Approval Plays Into Novartis’s Multipronged IgAN Approach

Atrasentan Joins Iptacopan On The Market

 
• By Alaric DeArment and Andrew McConaghie
  
Kidney cancer
(Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip